Search research articles
Contact Us
Filters
Showing results (161-170 of 166) with videos related to
Page
of 17
Sort By:
You have reached the last page of results.
This site can display upto 166 results.
European Urology
|
June 27, 2016
Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA Trial
Christopher Parker, Steven E Finkelstein, Jeff M Michalski, et al.
Blood
|
April 15, 1997
Adenosine deaminase deficiency in adults
H Ozsahin, F X Arredondo-Vega, I Santisteban, et al.
Stem Cells (Dayton, Ohio)
|
February 8, 2012
Derivation and functional analysis of patient-specific induced pluripotent stem cells as an in vitro model of chronic granulomatous disease
Yan Jiang, Sally A Cowley, Ulrich Siler, et al.
NPJ Parkinson'S Disease
|
May 29, 2023
Combining skin and olfactory α-synuclein seed amplification assays (SAA)-towards biomarker-driven phenotyping in synucleinopathies
A Kuzkina, J Rößle, A Seger, et al.
Blood
|
October 24, 2002
Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000
Reinhard A Seger, Tayfun Gungor, Bernd H Belohradsky, et al.
The Journal of Allergy and Clinical Immunology
|
July 8, 2008
Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome
Ellen D Renner, Stacey Rylaarsdam, Stephanie Anover-Sombke, et al.
Page
of 17
Search research articles
Search
Showing results (161-170 of 166) with videos related to
Sort By:
Page
of 17
You have reached the last page of results.
This site can display upto 166 results.
European Urology
|
June 27, 2016
Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA Trial
Christopher Parker, Steven E Finkelstein, Jeff M Michalski, et al.
Blood
|
April 15, 1997
Adenosine deaminase deficiency in adults
H Ozsahin, F X Arredondo-Vega, I Santisteban, et al.
Stem Cells (Dayton, Ohio)
|
February 8, 2012
Derivation and functional analysis of patient-specific induced pluripotent stem cells as an in vitro model of chronic granulomatous disease
Yan Jiang, Sally A Cowley, Ulrich Siler, et al.
NPJ Parkinson'S Disease
|
May 29, 2023
Combining skin and olfactory α-synuclein seed amplification assays (SAA)-towards biomarker-driven phenotyping in synucleinopathies
A Kuzkina, J Rößle, A Seger, et al.
Blood
|
October 24, 2002
Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000
Reinhard A Seger, Tayfun Gungor, Bernd H Belohradsky, et al.
The Journal of Allergy and Clinical Immunology
|
July 8, 2008
Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome
Ellen D Renner, Stacey Rylaarsdam, Stephanie Anover-Sombke, et al.
Page
of 17